Page last updated: 2024-11-05

triamterene and Ureteral Obstruction

triamterene has been researched along with Ureteral Obstruction in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, DM1
Threlfall, G1
Buck, AT1

Other Studies

1 other study available for triamterene and Ureteral Obstruction

ArticleYear
Chemically-induced renal hypertrophy in the rat.
    Biochemical pharmacology, 1968, Volume: 17, Issue:8

    Topics: Animals; DNA; Folic Acid; Hypertrophy; Kidney; Kidney Diseases; Male; Methotrexate; Organ Size; Pyri

1968